Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating post-surgery radiation treatment for Dupuytren's disease

Official title: Efficacy of Post-contracture Release Radiation for the Treatment of Dupuytren's Disease

Run by University of Minnesota · NCT04122313 · Data updated 2026-11-12

This study is testing whether adding radiation treatment after surgery for Dupuytren's disease can help improve hand function and reduce symptoms for patients.

More Dupuytren Contracture trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity of Minnesota
Academic / other
Drugs / interventionsradiation
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedMay 31, 2019
Main results expectedMarch 1, 2029
Study endsMarch 1, 2029
Registry record updatedMarch 19, 2026
Trial IDNCT04122313 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are English-speaking individuals diagnosed with Dupuytren's disease who are actively seeking treatment.

Probably not a fit

Patients with Dupuytren's disease who are not currently seeking treatment will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational pilot study aims to assess the effectiveness of a treatment pathway for Dupuytren's disease, which includes surgical contracture release followed by radiation therapy. Participants will receive a standard treatment involving limited fasciectomy, PNA, or CCH injection, followed by a series of radiation treatments. Data will be collected on participants' symptoms and hand function at various intervals to evaluate the clinical outcomes of the treatment. The study seeks to substantiate clinicians' impressions of patient improvement with scientific evidence.

Why it matters

Potential benefit: If successful, this study could provide evidence-based support for a treatment approach that may improve outcomes for patients with Dupuytren's disease.

How similar studies have gone: While this approach is based on established treatment protocols, the specific observational nature of this study may provide new insights into its effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnoses of Dupuytren's disease
* English-speaking

Exclusion Criteria:

\- Patients with Dupuytren's disease who are not currently seeking treatment

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.